Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heart Failure NYHA Class II”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Testing effectiveness (Phase 2)UnknownNCT05336175
What this trial is testing

Biomarker Study: Heart Failure Patients at Risk

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class IV
University of Arizona 40
Not applicableStudy completedNCT06641284
What this trial is testing

Gender-Based Differences in Heart Failure Hospitalizations Among Patients With Heart Failure Treated With Spironolactone

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure NYHA Class II+2 more
Ahmad Abdullah Salawi 509
Large-scale testing (Phase 3)Ended earlyNCT03909295
What this trial is testing

An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Ended earlyNCT00283361
What this trial is testing

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

Who this might be right for
Heart Failure, Congestive
Zealand Pharma 130
Not applicableLooking for participantsNCT07817589
What this trial is testing

Yoga Based Cardiac Rehabilitation in Heart Failure Failure

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart Failure NYHA Class IIHeart Failure NYHA Class III
Centre for Chronic Disease Control, India 3,500
Not applicableStudy completedNCT03095196
What this trial is testing

Multipolar CRT-d and Diabetes

Who this might be right for
DiabetesHeart FailureHeart Failure NYHA Class II+1 more
Celestino Sardu 190
Not applicableStudy completedNCT01452802
What this trial is testing

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

Who this might be right for
Heart Failure
Abbott Medical Devices 200
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00461058
What this trial is testing

A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 14
Testing effectiveness (Phase 2)WithdrawnNCT07221513
What this trial is testing

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc
Not applicableLooking for participantsNCT05934487
What this trial is testing

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure
Endotronix, Inc. 1,750
Large-scale testing (Phase 3)Study completedNCT01920711
What this trial is testing

Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Novartis Pharmaceuticals 4,822
Large-scale testing (Phase 3)Study completedNCT03066804
What this trial is testing

A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Novartis Pharmaceuticals 2,572
Not applicableLooking for participantsNCT06313684
What this trial is testing

Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart Failure

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class III
Universidad de La Frontera 152
Early research (Phase 1)Study completedNCT02388464
What this trial is testing

A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure

Who this might be right for
Congestive Heart Failure
Stealth BioTherapeutics Inc. 36
Not applicableStudy completedNCT03035565
What this trial is testing

Cognitive Intervention to Improve Memory in Heart Failure Patients

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class I
Indiana University 276
Testing effectiveness (Phase 2)WithdrawnNCT03005184
What this trial is testing

Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

Who this might be right for
Heart Failure NYHA Class IHeart Failure NYHA Class IIHeart Failure NYHA Class III
Vanderbilt University Medical Center
Not applicableStudy completedNCT07045038
What this trial is testing

Blood Flow Restricted Resistance Exercises Versus Low Level Laser on Cardiac Functions in Patients With Chronic Heart Failure

Who this might be right for
Heart Failure NYHA Class II
Cairo University 60
Not applicableLooking for participantsNCT06646601
What this trial is testing

A Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patients Suffering from Cardio-neurovascular Pathology and to Those Involved in the Action.

Who this might be right for
Vascular DiseaseCardiovascularAtrial Fibrillation (AF)+4 more
Assistance Publique Hopitaux De Marseille 157
Post-approval studies (Phase 4)UnknownNCT05702970
What this trial is testing

Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency

Who this might be right for
Heart FailureIron-deficiencyHeart Failure, Systolic+3 more
University of Padova 258
Next Page